Sun Young Yoon

USPTO Granted Patents = 8 (Patent Applications = 11)

EPO Patents = 3 (Patent Applications = 17)

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Daejeon, KR (2023)
Seoul, KR (2016 - 2024)

Company Filing History:

4 out of 22

Enzychem Lifesciences Corporation

patents

3 out of 4

Industry-Academic Cooperation Foundation, Sookmyung Women's University

patents

3 out of 14

Il-Yang Pharm. Co., Ltd

patents

4. 2 out of 124

Samsung Life Public Welfare Foundation

Samsung Life Welfare Foundation

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297163 - Glycerol derivative, preparation method therefor, and immunomodulator comprising same as effective ingredient (2025-05-13),

2. 12187672 - 1,2-diacylglycerol compound, preparation method therefor, and immunomodulator containing same as active ingredient (2025-01-07),

3. 12076307 - Compositions for prevention or treatment of acute radiation syndrome and other radiation exposure (2024-09-03),

4. 11590096 - Compositions for prevention or treatment of acute radiation syndrome and other radiation exposure (2023-02-28),

5. 10446107 - Data driver and display apparatus including the same (2019-10-15),

6. 9938320 - Peptides for promoting angiogenesis and use thereof (2018-04-10),

7. 9610318 - Peptides for promoting angiogenesis and use thereof (2017-04-04),

8. 9249185 - Peptides for promoting angiogenesis and an use thereof (2016-02-02),

Title: Sun Young Yoon: Innovator in Immunomodulation

Introduction

Sun Young Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunomodulation, holding a total of eight patents. His work focuses on developing novel compounds that can improve, prevent, or treat inflammation-related diseases.

Latest Patents

Among his latest patents is a glycerol derivative that is effective in treating inflammation-related diseases by inhibiting the overexpression of inflammatory cytokines such as IL-4 and IL-6. This patent also includes a preparation method for the glycerol derivative and an immunomodulator that contains it as an active ingredient. Another notable patent involves a novel 1,2-diacylglycerol compound, which similarly targets inflammation-related diseases by reducing the migration of inflammatory cells. This compound is also represented in the patent specification and is accompanied by a method for its preparation.

Career Highlights

Sun Young Yoon has worked with several organizations, including Enzychem Lifesciences Corporation and the Industry-Academic Cooperation Foundation at Sookmyung Women's University. His career reflects a strong commitment to advancing research in immunology and related fields.

Collaborations

Some of his notable coworkers include Ki Young Sohn and Dae Ho Cho, who have contributed to his research endeavors.

Conclusion

Sun Young Yoon's innovative work in immunomodulation and his numerous patents highlight his significant impact on the field. His contributions continue to pave the way for advancements in treating inflammation-related diseases.

This text is generated by artificial intelligence and may not be accurate.